Interest-bearing debt
Pass0.0%of market cap
0%limit 30%
Filed balance sheet (Form 10-Q, period ending 2026-06-30): no borrowings; every liability line is accounted for
TXGNasdaq
Life Sciences Tools & Services
Verdict
Passes the business-activity screen and all three AAOIFI financial tests, each from 10X Genomics Inc's own filings.
AAOIFI Shari'ah Standard No. 21 · screened 16 Oct 2026
Each bar shows the figure against its limit; the line marks the limit.
0.0%of market cap
Filed balance sheet (Form 10-Q, period ending 2026-06-30): no borrowings; every liability line is accounted for
5.3%of market cap
Filed financial statements
3.6%of revenue
No prohibited activity (alcohol, gambling, tobacco, conventional finance, pork, adult content) found in the sector, SEC industry or company name.
See the business + financial screening, dividend purification ratio, and category-by-category compliance status.
Upgrade to ProFiled financial statements